SCHEMBL1069771

SCHEMBL1069771

O=S(=O)(NC(F)(F)F)c1cccc(-c2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 3/20 0.50
PFKFB3 Q16875 1/20 0.49
ACLY P53396 1/20 0.47
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
MMP1 P03956 1/20 0.46
MMP2 P08253 1/20 0.46
MMP9 P14780 1/20 0.46
MMP8 P22894 1/20 0.46
MMP13 P45452 1/20 0.46
EDNRB P24530 3/20 0.46
EDNRA P25101 3/20 0.46
PGR P06401 1/20 0.45
PTPN1 P18031 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL28160349 0.92 PFKFB3 (0.50) PTGES2PFKFB3ACLYCA1CA2
SCHEMBL1068742 0.84 MMP1 (0.50) ACLYCA1CA2MMP1MMP2
SCHEMBL302571 0.83 GAA (0.55) CA1CA2MMP1MMP2MMP9
SCHEMBL28783847 0.83 MAPT (0.67) PTGES2PFKFB3EDNRBEDNRAPGR
Hydrochloric Acid SCHEMBL16015051 0.82 MMP1 (0.49) ACLYCA1CA2MMP1MMP2
Hydrochloric Acid SCHEMBL2640192 0.81 GAA (0.54) CA1CA2MMP1MMP2MMP9
SCHEMBL13485830 0.78 CA1 (0.69) PTGES2PFKFB3ACLYCA1CA2
SCHEMBL5899418 0.77 PFKFB3 (0.54) PTGES2PFKFB3ACLYKDM4EMEN1
SCHEMBL5250778 0.77 KMT2A (0.46) CA1CA2MMP1MMP2MMP9
SCHEMBL30437048 0.77 PTGES2 (0.58) PTGES2PFKFB3CA1CA2MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2451285-A1 PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONISTS Merck Sharp & Dohme Corp. (US) 2012-05-16 EP claimed
WO-2011005608-A1 PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2011-01-13 WO claimed
CN-105102449-B Antiviral compound 豪夫迈·罗氏有限公司 2017-06-13 CN disclosed
EP-3096754-A1 METALLO-BETA-LACTAMASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2016-11-30 EP disclosed
EP-2964635-A1 ANTIVIRAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2016-01-13 EP disclosed
WO-2015112441-A1 METALLO-BETA-LACTAMASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-07-30 WO disclosed
WO-2014135495-A1 ANTIVIRAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2014-09-12 WO disclosed